Lag3 blockade enhances the anti-tumor effect of dual GITR agonism and PD-1 blockade in a preclinical melanoma model

被引：0
|
作者：
Maniyar, Rachana R.
Elhanati, Yuval
Mangarin, Levi
Marouf, Yacine
Ahmed, Ashley
Greenbaum, Benjamin
Wolchok, Jedd
Merghoub, Taha
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-4034
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4034
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Anti-tumor immunotherapy by blockade of the PD-1/PD-L1 pathway with recombinant human PD-1-IgV
    Zhang, C.
    Wu, S.
    Xue, X.
    Li, M.
    Qin, X.
    Li, W.
    Han, W.
    Zhang, Y.
    CYTOTHERAPY, 2008, 10 (07) : 711 - 719
  • [42] PD-1 and LAG-3 dual blockade: emerging mechanisms and potential therapeutic prospects in cancer
    Qiu, Xiangyu
    Yu, Zhaoan
    Lu, Xiaoqing
    Jin, Xin
    Zhu, Jinrong
    Zhang, Rongxin
    CANCER BIOLOGY & MEDICINE, 2024, 21 (11) : 970 - 976
  • [43] PD-1 and LAG-3 dual blockade: emerging mechanisms and potential therapeutic prospects in cancer
    Xiangyu Qiu
    Zhaoan Yu
    Xiaoqing Lu
    Xin Jin
    Jinrong Zhu
    Rongxin Zhang
    Cancer Biology & Medicine, 2024, 21 (11) : 970 - 976
  • [44] Different Expression Characteristics of LAG3 and PD-1 in Sepsis and Their Synergistic Effect on T Cell Exhaustion: A New Strategy for Immune Checkpoint Blockade
    Niu, Bailin
    Zhou, Fachun
    Su, Yanxin
    Wang, Long
    Xu, Yuanyuan
    Yi, Ziying
    Wu, Yushen
    Du, Huimin
    Ren, Guosheng
    FRONTIERS IN IMMUNOLOGY, 2019, 10
  • [45] Resistance to PD1 blockade in the absence of metalloprotease-mediated LAG3 shedding
    Andrews, Lawrence P.
    Somasundaram, Ashwin
    Moskovitz, Jessica M.
    Szymczak-Workman, Andrea L.
    Liu, Chang
    Cillo, Anthony R.
    Lin, Huang
    Normolle, Daniel P.
    Moynihan, Kelly D.
    Taniuchi, Ichiro
    Irvine, Darrell J.
    Kirkwood, John M.
    Lipson, Evan J.
    Ferris, Robert L.
    Bruno, Tullia C.
    Workman, Creg J.
    Vignali, Dario A. A.
    SCIENCE IMMUNOLOGY, 2020, 5 (49)
  • [46] Resistance to PD1 blockade in the absence of metalloprotease-mediated LAG3 shedding
    Andrews, Lawrence Peter
    Moskovitz, Jessica
    Szynnczak-Workman, Andrea L.
    Bruno, Tullia C.
    Workman, Creg J.
    Vignali, Dario A. A.
    JOURNAL OF IMMUNOLOGY, 2017, 198 (01):
  • [47] SEX-LINKED DIFFERENCES IN OBESITY MARKEDLY IMPACT THE ANTI-TUMOR EFFICACY OF PD-1 BLOCKADE
    Vick, Logan
    Wang, Ziming
    Collins, Craig
    Khuat, Lam
    Dunai, Cordelia
    Stoffel, Kevin
    Yendamuri, Sai
    Mukherjee, Sarbajit
    Rosario, Spencer
    Canter, Robert
    Monjazeb, Arta
    Murphy, William
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A560 - A560
  • [48] Anti-tumor immunity evolved by novel titanium peroxide nanoparticles (TiOxNPs) as a radiosensitizer and PD-1 blockade
    Fujita, Yoshiko
    Kubota, Hikaru
    Ogino, Chiaki
    Sasaki, Ryohei
    CANCER RESEARCH, 2023, 83 (07)
  • [49] RETRACTED: Dual Blockade of PD-1 and LAG3 Immune Checkpoints Increases Dendritic Cell Vaccine Mediated T Cell Responses in Breast Cancer Model (Retracted Article)
    Barshidi, Asal
    Karpisheh, Vahid
    Noukabadi, Fatemeh Karimian
    Kiani, Fariba Karoon
    Mohammadi, Mohammad
    Afsharimanesh, Negin
    Ebrahimi, Farbod
    Kiaie, Seyed Hossein
    Navashenaq, Jamshid Gholizadeh
    Hojjat-Farsangi, Mohammad
    Zolbanin, Naime Majidi
    Mahmoodpoor, Ata
    Hassannia, Hadi
    Nami, Sanam
    Jalali, Pooya
    Jafari, Reza
    Jadidi-Niaragh, Farhad
    PHARMACEUTICAL RESEARCH, 2022, 39 (08) : 1851 - 1866
  • [50] Tumor cell oxidative metabolism as a barrier to PD-1 blockade immunotherapy in melanoma
    Najjar, Yana G.
    Menk, Ashley, V
    Sander, Cindy
    Rao, Uma
    Karunamurthy, Arivarasan
    Bhatia, Roma
    Zhai, Shuyan
    Kirkwood, John M.
    Delgoffe, Greg M.
    JCI INSIGHT, 2019, 4 (05)
12345